Treatment of Upper Extremity Deep-Vein Thrombosis.
Phase of Trial: Phase IV
Latest Information Update: 15 Feb 2013
At a glance
- Drugs Dalteparin sodium (Primary)
- Indications Deep vein thrombosis
- Focus Therapeutic Use
- 28 Feb 2012 Actual patient number is 67 according to ClinicalTrials.gov.
- 28 Feb 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 07 Feb 2011 Planned end date changed from 1 Sep 2009 to 1 Dec 2011 as reported by ClinicalTrials.gov.